Here's Why Synchrony (SYF) is a Strong Momentum Stock — Positive
SYF Zacks Investment Research — May 19, 2025Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Reinsurance Group (RGA) is a Strong Momentum Stock — Positive
RGA Zacks Investment Research — May 19, 2025Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Wall Street Analysts Think Rambus (RMBS) Could Surge 28.22%: Read This Before Placing a Bet — Positive
RMBS Zacks Investment Research — May 19, 2025The consensus price target hints at a 28.2% upside potential for Rambus (RMBS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Wall Street Analysts See a 34.92% Upside in CI&T (CINT): Can the Stock Really Move This High? — Positive
CINT Zacks Investment Research — May 19, 2025The consensus price target hints at a 34.9% upside potential for CI&T (CINT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Wall Street Analysts Predict a 28.13% Upside in Energy Transfer LP (ET): Here's What You Should Know — Positive
ET Zacks Investment Research — May 19, 2025The average of price targets set by Wall Street analysts indicates a potential upside of 28.1% in Energy Transfer LP (ET). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Does West Pharmaceutical (WST) Have the Potential to Rally 31.09% as Wall Street Analysts Expect? — Positive
WST Zacks Investment Research — May 19, 2025The average of price targets set by Wall Street analysts indicates a potential upside of 31.1% in West Pharmaceutical (WST). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Wall Street Analysts Predict a 37.73% Upside in HNI (HNI): Here's What You Should Know — Positive
HNI Zacks Investment Research — May 19, 2025The average of price targets set by Wall Street analysts indicates a potential upside of 37.7% in HNI (HNI). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Does Karyopharm Therapeutics (KPTI) Have the Potential to Rally 521.62% as Wall Street Analysts Expect? — Positive
KPTI Zacks Investment Research — May 19, 2025The average of price targets set by Wall Street analysts indicates a potential upside of 521.6% in Karyopharm Therapeutics (KPTI). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Here's Why Motorola (MSI) is a Strong Growth Stock — Positive
MSI Zacks Investment Research — May 19, 2025The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Domino's Pizza (DPZ) is a Top Growth Stock for the Long-Term — Positive
DPZ Zacks Investment Research — May 19, 2025Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why ResMed (RMD) is a Strong Growth Stock — Positive
RMD Zacks Investment Research — May 19, 2025The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why TJX (TJX) is a Top Growth Stock for the Long-Term — Positive
TJX Zacks Investment Research — May 19, 2025Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Charter Communications (CHTR) is a Top Growth Stock for the Long-Term — Positive
CHTR Zacks Investment Research — May 19, 2025Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
WILMINGTON, Mass., May 19, 2025 (GLOBE NEWSWIRE) -- UniFirst Corporation (NYSE: UNF) today announced that Steven S. Sintros, President and Chief Executive Officer and Shane F. O'Connor, Executive Vice President and Chief Financial Officer, will participate in the Baird 2025 Global Consumer, Technology & Services Conference on June 4, 2025 with a featured presentation at 9:40am Eastern Time. The conference is being held at the InterContinental New York Barclay at 111 East 48th Street in New York City. They will discuss UniFirst's business highlights as well as information concerning recent business trends.
I Still Like Village Farms For Cannabis Investors Despite The Big Rally — Positive
VFF Seeking Alpha — May 19, 2025Village Farms' spin-off of its produce business will transform it into a pure-play cannabis company, unlocking value and simplifying its structure. Despite a recent 57% rally, VFF remains undervalued relative to peers, with a strong balance sheet and significant upside potential based on EBITDA multiples. Key risks include the Vanguard JV deal not closing, warrant overhang, and NASDAQ compliance, but the $40M cash inflow should strengthen the company's position.
How Bill Ackman predicted UnitedHealth stock crash two months early — Negative
UNH Finbold — May 19, 2025While the deluge of recent negative news has made it apparent to all that UnitedHealth (NYSE: UNH) stock is in dire straits, Bill Ackman saw the writing on the wall months in advance.
Rosen Law Firm Encourages Backblaze, Inc. Investors to Inquire About Securities Class Action Investigation - BLZE — Neutral
BLZE PRNewsWire — May 19, 2025NEW YORK , May 19, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Backblaze, Inc. (NASDAQ: BLZE) resulting from allegations that Backblaze may have issued materially misleading business information to the investing public. So What: If you purchased Backblaze securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
India's gold market softened in April, but price stabilization could reignite demand – WGC's Chacko — Neutral
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL UGL Kitco — May 19, 2025Ernest Hoffman is a Crypto and Market Reporter for Kitco News. He has over 15 years of experience as a writer, editor, broadcaster and producer for media, educational and cultural organizations.
Booz Allen Hamilton (BAH) is a Top-Ranked Value Stock: Should You Buy? — Positive
BAH Zacks Investment Research — May 19, 2025The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Conmed (CNMD) is a Strong Value Stock — Positive
CNMD Zacks Investment Research — May 19, 2025Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
